We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+26.29%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$232M
AUM Growth
+$45.2M
Cap. Flow
-$565K
Cap. Flow %
-0.24%
Top 10 Hldgs %
78.3%
Holding
56
New
3
Increased
6
Reduced
12
Closed
3

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$235K
2
V icon
Visa
V
+$228K
3
INTU icon
Intuit
INTU
+$218K
4
WU icon
Western Union
WU
+$203K
5
T icon
AT&T
T
+$196K

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$556K
2
AAPL icon
Apple
AAPL
+$323K
3
ED icon
Consolidated Edison
ED
+$207K
4
ADBE icon
Adobe
ADBE
+$178K
5
LLY icon
Eli Lilly
LLY
+$148K

Sector Composition

Rank Sector Weight
1 Technology 44.91%
2 Healthcare 31.94%
3 Communication Services 9.4%
4 Consumer Discretionary 5.28%
5 Industrials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILMN icon
26
Illumina
ILMN
$28.4B
$1.19M 0.51%
3,290
TSLA icon
27
Tesla
TSLA
$1.3T
$907K 0.39%
12,600
PFE icon
28
Pfizer
PFE
$153B
$882K 0.38%
28,436
INTC icon
29
Intel
INTC
$513B
$771K 0.33%
12,890
PEP icon
30
PepsiCo
PEP
$190B
$744K 0.32%
5,625
PEG icon
31
Public Service Enterprise Group
PEG
$37.7B
$743K 0.32%
15,122
LLY icon
32
Eli Lilly
LLY
$1.06T
$704K 0.3%
4,289
-964
-18% -$148K
BSX icon
33
Boston Scientific
BSX
$71.5B
$625K 0.27%
17,789
VZ icon
34
Verizon
VZ
$196B
$579K 0.25%
10,508
GILD icon
35
Gilead Sciences
GILD
$165B
$574K 0.25%
7,455
MRK icon
36
Merck
MRK
$318B
$516K 0.22%
6,987
LOW icon
37
Lowe's Companies
LOW
$125B
$473K 0.2%
3,500
MCHP icon
38
Microchip Technology
MCHP
$46B
$418K 0.18%
7,930
PG icon
39
Procter & Gamble
PG
$339B
$417K 0.18%
3,491
VAR
40
DELISTED
Varian Medical Systems, Inc.
VAR
$366K 0.16%
2,990
HD icon
41
Home Depot
HD
$355B
$363K 0.16%
1,450
CNP icon
42
CenterPoint Energy
CNP
$26.8B
$317K 0.14%
16,966
CTSH icon
43
Cognizant
CTSH
$26B
$284K 0.12%
5,000
-300
-6% -$16.1K
BNY
44
Bank of New York Mellon
BNY
$107B
$271K 0.12%
7,000
SYK icon
45
Stryker
SYK
$130B
$270K 0.12%
1,500
BA icon
46
Boeing
BA
$185B
$262K 0.11%
1,428
HRL icon
47
Hormel Foods
HRL
$13.8B
$251K 0.11%
5,195
EOG icon
48
EOG Resources
EOG
$70.7B
$246K 0.11%
+4,851
New +$235K
INTU icon
49
Intuit
INTU
$89B
$236K 0.1%
+795
New +$218K
ABT icon
50
Abbott
ABT
$187B
$235K 0.1%
2,568

Similar funds

Bourne Lent Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Bourne Lent Asset Management held 56 positions worth $232M, up 24% from $186M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bourne Lent Asset Management's Q2 2020 filing shows 3 new, 6 increased, 12 reduced and 3 closed positions. Its largest new stake was EOG Resources: 4,851 shares worth $246K. The largest sale was Idexx Laboratories, an estimated $556K.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.

  • Bourne Lent Asset Management's largest Q2 2020 buy was EOG Resources: 4,851 shares worth $246K.
  • Bourne Lent Asset Management added most to Visa in Q2 2020, an estimated $228K increase.
  • Bourne Lent Asset Management's biggest Q2 2020 reduction was Idexx Laboratories, cutting an estimated $556K.
  • Bourne Lent Asset Management fully exited Consolidated Edison in Q2 2020, selling an estimated $207K.
  • Bourne Lent Asset Management's ten largest holdings make up 78% of its $232M portfolio in Q2 2020.
  • Bourne Lent Asset Management opened 3 new positions and closed 3 in Q2 2020.
  • Bourne Lent Asset Management's portfolio value rose 24% quarter-over-quarter to $232M.

Based on Bourne Lent Asset Management's 13F filing for Q2 2020, filed 20 Jul 2020.